Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

National Injectable Opioid Agonist Treatment Guideline

The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT.
Guidelines | 2019
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Illegal drugs, Stimulants, Transitions in care/treatment, Injecting drugs

Problems with hydromorphone prescribing as a response to the opioid crisis

Various practical and theoretical arguments against take-home opioid maintenance programs
Letter | 2020
Policy/Regulatory, Safer supply

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis

To describe opioid agonist treatment prescribing rates in provincial prisons and compare with community prescribing rates.
Original research | 2021
About prescribers, Legal system/law enforcement, Substitution/OAT

RE: Problems with hydromorphone prescribing as a response to the opioid crisis

Response to Tyndall

Commentary | 2019
Harm reduction, Policy/Regulatory, About prescribers, Injecting drugs

Regarding Issues of the Safe Supply Options for Opioids in the “Risk Mitigation in the Context of Dual Public Health Emergencies” Guideline

Inform PWUD about the costs and benefits of the Safe Supply options
Commentary | 2020
Policy/Regulatory, Safer supply, Advocacy, About PWUD

Research 101: A Manifesto for Ethical Research in the Downtown Eastside

This manifesto builds on, and complements, the work of many other DTES organizations to empower themselves in setting up more equitable and ethical partnerships with researchers.

Report | 2019
About PWUD, Peer/PWLLE program involvement

Safe Supply Concept Document

To outline the concept of safe supply including its role in drug policy
Commentary | 2019
Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Stimulants

Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization

Scoping review to identify key concepts, strategies and gaps in evidence with respect to the provision of safe supply during pandemics and other emergencies.

Scoping review | 2020
Policy/Regulatory, Safer supply, About prescribers, About PWUD, Barriers and enablers

Smartphone applications for intervening on addictive behaviors: efficacy is just one phase of the marathon

Commentary on Khadjesari et al 2021
Commentary | 2021
Digital health

The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada

To examine temporal trends in prescription opioid (PO) injection and to assess its association with hepatitis C virus (HCV) seroconversion among people who inject drugs (PWID).
Original research | 2019
Evidence base, Safer supply, About prescribers

Virtual Overdose Response for People Who Use Opioids Alone: Protocol for a Feasibility and Clinical Trial Study

This clinical trial aims to test the feasibility of a service that provides virtual overdose response in order to help prevent deaths in populations that cannot or will not access physical supervised
Other | 2021
Overdose, Harm reduction, Illegal drugs

Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications

In September 2020, xylazine was first detected by Toronto’s Drug Checking Service
Original research | 2021
Overdose, Mortality, Harm reduction, Policy/Regulatory, Decriminalization/legalization, Drug checking

Yet they failed to do so: recommendations based on the experiences of NAOMI research survivors and a call for action

Drawing on brainstorming sessions and focus groups that were conducted in the summer of 2011, this paper highlights the experiences of NPA members in their own words.
Original research | 2013
Policy/Regulatory, Wrap-around services, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Social services, Outcomes, Peer/PWLLE program involvement, Social benefits, Stigma

BCCSU Webinars

Archived webinar | various
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Injecting drugs

BCCSU Webinars: COVID-19, Substance Use, and Safer Supply

Archived webinar | 2020
Clinical guidance, Harm reduction, Safer supply, About pharmacists, About prescribers, Housing

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

The current study aimed to compare the cost-effectiveness of hydromorphone directly with diacetylmorphine and indirectly with methadone maintenance treatment.
Original research | 2018
Evidence base, Safer supply, Crime, Substitution/OAT

Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada

PO diversion is widely regarded as a driver of OD mortality.
Original research | 2021
Harm reduction, Safer supply, About PWUD, Barriers and enablers, Poverty, Diversion

Fentanyl Buccal Tablet In Breakthrough Pain in Opioid-Tolerant Patients with Cancer

Report | 2006
Clinical guidance, Chronic pain

Guidance for Injectable Opiod Agonist Treatment for Opioid Use Disorder

Guidelines | 2017
Clinical guidance, Evidence base, Policy/Regulatory, About prescribers

Guideline for the Clinical Management of Opioid Use Disorder

Guidelines | 2023
Clinical guidance, Policy/Regulatory, About prescribers

Refine Your Search

Keywords
Format
Region